HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Albert Oriol Selected Research

Hematopoietic Stem Cell Transplantation

5/2014Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.
11/2011Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study.
7/2004Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Albert Oriol Research Topics

Disease

123Multiple Myeloma
04/2024 - 10/2006
20Neoplasms (Cancer)
10/2023 - 10/2007
14Disease Progression
01/2024 - 11/2012
9Pneumonia (Pneumonitis)
10/2023 - 11/2011
7Thrombocytopenia (Thrombopenia)
10/2023 - 07/2012
7Infections
10/2023 - 04/2003
7Neutropenia
10/2023 - 07/2012
7Residual Neoplasm
01/2023 - 01/2012
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 02/2003
7Leukemia
10/2014 - 04/2003
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2016 - 05/2005
6Lymphoma (Lymphomas)
12/2014 - 09/2002
6Burkitt Lymphoma (Burkitt's Lymphoma)
10/2014 - 04/2003
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2014 - 09/2005
5Chromosome Aberrations (Chromosome Abnormalities)
10/2023 - 09/2007
5Peripheral Nervous System Diseases (PNS Diseases)
08/2021 - 10/2010
5AIDS-Related Lymphoma (Lymphoma, AIDS Related)
11/2014 - 09/2002
5Pathologic Complete Response
10/2010 - 10/2005
4Sepsis (Septicemia)
10/2023 - 09/2019
4Smoldering Multiple Myeloma
10/2022 - 08/2013
4Fatigue
10/2017 - 06/2010
3Septic Shock (Toxic Shock Syndrome)
10/2023 - 11/2011
3Hypertension (High Blood Pressure)
12/2020 - 01/2016
3Heart Arrest (Cardiac Arrest)
09/2019 - 10/2017
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
04/2017 - 02/2008
3Acquired Immunodeficiency Syndrome (AIDS)
03/2011 - 07/2005
3B-Cell Lymphoma (Lymphoma, B Cell)
11/2007 - 04/2003
2Plasmacytoma
09/2023 - 05/2019
2Diarrhea
01/2023 - 12/2020
2Body Weight (Weight, Body)
12/2022 - 11/2022
2Circulating Neoplastic Cells
11/2022 - 01/2022
2Inborn Genetic Diseases (Disease, Hereditary)
01/2022 - 01/2022
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2021 - 12/2020
2Paraproteinemias (Monoclonal Gammopathy)
10/2021 - 08/2014
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020 - 04/2017
2Myocarditis (Carditis)
09/2019 - 09/2019
2Respiratory Insufficiency (Respiratory Failure)
09/2019 - 11/2011
2Immunoglobulin Light-chain Amyloidosis
01/2019 - 09/2015
2Anemia
02/2017 - 10/2016
2Philadelphia Chromosome
11/2012 - 01/2010
2HIV Infections (HIV Infection)
07/2008 - 04/2003
2Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2007 - 10/2005
1Frailty
11/2023

Drug/Important Bio-Agent (IBA)

66Dexamethasone (Maxidex)FDA LinkGeneric
03/2024 - 10/2007
39Bortezomib (Velcade)FDA Link
02/2024 - 10/2006
39Lenalidomide (CC 5013)FDA Link
11/2023 - 03/2011
21pomalidomideIBA
03/2024 - 10/2013
20daratumumabIBA
02/2024 - 04/2016
19carfilzomibIBA
03/2024 - 01/2015
16Prednisone (Sone)FDA LinkGeneric
08/2021 - 05/2005
12Melphalan (Alkeran)FDA LinkGeneric
08/2021 - 10/2006
11Proteasome InhibitorsIBA
10/2023 - 01/2015
10Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2023 - 05/2005
10Monoclonal AntibodiesIBA
01/2023 - 04/2016
9Immunomodulating AgentsIBA
03/2024 - 09/2015
8Thalidomide (Thalomid)FDA Link
01/2023 - 10/2010
8Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2018
8Rituximab (Mabthera)FDA Link
11/2021 - 09/2002
7Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2019
6Vincristine (Oncovin)FDA LinkGeneric
01/2016 - 05/2005
5pembrolizumabIBA
04/2024 - 09/2019
5isatuximabIBA
09/2023 - 01/2021
4B-Cell Maturation AntigenIBA
09/2023 - 01/2021
4melflufenIBA
08/2023 - 10/2020
4Alkylating AgentsIBA
05/2021 - 09/2014
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016 - 02/2008
3AntibodiesIBA
10/2023 - 01/2020
3bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
09/2023 - 01/2021
3Peptides (Polypeptides)IBA
08/2023 - 10/2020
3ibrutinibIBA
11/2021 - 05/2020
3Nerve Growth Factor (NGF)IBA
01/2021 - 10/2020
3Cytarabine (Cytosar-U)FDA LinkGeneric
01/2014 - 07/2004
2Immunoglobulins (Immunoglobulin)IBA
11/2023 - 01/2020
2Death Domain ReceptorsIBA
10/2023 - 01/2021
2plitidepsin (aplidine)IBA
01/2023 - 06/2010
2ParaproteinsIBA
01/2022 - 05/2019
2AminopeptidasesIBA
01/2021 - 10/2020
2idecabtagene vicleucelIBA
01/2021 - 01/2021
2Chimeric Antigen ReceptorsIBA
01/2021 - 01/2020
2DecitabineFDA Link
01/2018 - 07/2012
2fludarabineIBA
04/2017 - 02/2008
2Mitoxantrone (Novantrone)FDA LinkGeneric
04/2017 - 02/2008
2Etoposide (VP 16)FDA LinkGeneric
11/2013 - 02/2003
2Imatinib Mesylate (Gleevec)FDA Link
01/2010 - 09/2007
2Protons (Proton)IBA
11/2009 - 04/2007
2Methotrexate (Mexate)FDA LinkGeneric
02/2007 - 11/2005
2AntigensIBA
01/2006 - 09/2005
1belantamab mafodotinIBA
04/2024
1selinexorIBA
02/2024
1Immune Checkpoint ProteinsIBA
01/2024
1ParaffinIBA
10/2023

Therapy/Procedure

46Therapeutics
10/2023 - 04/2003
18Stem Cell Transplantation
12/2021 - 07/2004
16Drug Therapy (Chemotherapy)
10/2015 - 09/2002
7Highly Active Antiretroviral Therapy (HAART)
02/2008 - 09/2002
5Aftercare (After-Treatment)
12/2020 - 10/2005
4Transplantation
01/2023 - 11/2011
3Immunotherapy
01/2020 - 07/2008
3Hematopoietic Stem Cell Transplantation
05/2014 - 07/2004
2Maintenance Chemotherapy
01/2007 - 10/2005